Development of a Quantitative FMRP Assay for Mouse Tissue Applications

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Fragile X syndrome is caused by the lack of Fragile X Mental Retardation Protein (FMRP).
• Existing methods for quantifying FMRP in animal models are unreliable.
• A robust assay is needed to advance Fragile X research.

Purpose of the Study:

• To develop and validate a quantitative method for assessing FMRP levels in mouse tissues.
• To establish baseline FMRP expression levels across different brain regions and mouse strains.
• To investigate developmental changes in FMRP expression.

Main Methods:

• Development of FMRP-specific monoclonal antibodies for quantitative assessment (qFMRPm).
• Analysis of FMRP expression in four brain structures (neocortex, hippocampus, cerebellum, brainstem) across six mouse strains at 7 weeks of age.
• Assessment of FMRP developmental changes in male mice at 3, 7, 10, and 14 weeks of age, including blood samples.

Main Results:

• Established a hierarchy of FMRP expression in the brain: neocortex > hippocampus > cerebellum > brainstem.
• Identified the neocortex as having the highest and least variable FMRP expression.
• Observed a general decline in FMRP expression with age in brain tissues, except for the brainstem, and a significant drop in blood FMRP levels after 3 weeks of age.

Conclusions:

• The quantitative FMRP (qFMRPm) assay is a reliable, cost-effective, and accurate tool for measuring FMRP.
• The assay provides valuable insights into FMRP expression patterns in mouse models of Fragile X syndrome.
• Understanding FMRP variability and developmental changes is crucial for Fragile X research.